SCHEMBL7705893

SCHEMBL7705893

CC(=O)Nc1cccc(-c2cc(N)n3nc(-c4ccccn4)nc3c2)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.52
FYN P06241 11/20 0.48
KIT P10721 1/20 0.46
FLT3 P36888 1/20 0.46
RXFP1 Q9HBX9 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MAPT P10636 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
STAT1 P42224 1/20 0.44
ATR Q13535 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708412 0.90 ADORA2A (0.54) ADORA2AKITFLT3RXFP1SMN1; SMN2
SCHEMBL7705969 0.88 MAPT (0.52) FYNRXFP1SMN1; SMN2NPC1RAB9A
SCHEMBL7708431 0.82 POLB (0.43) FYNRXFP1SMN1; SMN2MAPTKDM4E
SCHEMBL7709146 0.81 ADORA2A (0.52) ADORA2ASMN1; SMN2NPC1RAB9AMAPT
SCHEMBL7481320 0.81 ADORA2A (0.54) ADORA2AFYNFLT3SMN1; SMN2NPC1
SCHEMBL7484739 0.80 ADORA2A (0.52) ADORA2A
SCHEMBL7705871 0.80 FYN (0.55) ADORA2AFYNSMN1; SMN2NPC1RAB9A
SCHEMBL7481934 0.80 ADORA2A (0.54) ADORA2AFYNRXFP1SMN1; SMN2NPC1
SCHEMBL7703127 0.79 ADORA2A (0.52) ADORA2ASMN1; SMN2NPC1RAB9AMAPT
SCHEMBL7708837 0.79 GRM5 (0.52) ADORA2ASMN1; SMN2NPC1RAB9ANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed